Eyenovia Inc has a consensus price target of $10 based on the ratings of 3 analysts. The high is $12 issued by HC Wainwright & Co. on July 24, 2024. The low is $8 issued by Brookline Capital on October 17, 2023. The 3 most-recent analyst ratings were released by HC Wainwright & Co. on July 24, 2024, May 16, 2024, and March 19, 2024, respectively. With an average price target of $12 between HC Wainwright & Co., there's an implied 788.89% upside for Eyenovia Inc from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
07/24/2024 | Buy Now | 788.89% | HC Wainwright & Co. | Matthew Caufield | $12 → $12 | Reiterates | Buy → Buy | Get Alert |
05/16/2024 | Buy Now | 788.89% | HC Wainwright & Co. | Matthew Caufield | → $12 | Reiterates | Buy → Buy | Get Alert |
03/19/2024 | Buy Now | 788.89% | HC Wainwright & Co. | Matthew Caufield | → $12 | Reiterates | Buy → Buy | Get Alert |
03/06/2024 | Buy Now | 788.89% | HC Wainwright & Co. | Matthew Caufield | → $12 | Reiterates | Buy → Buy | Get Alert |
11/14/2023 | Buy Now | 788.89% | HC Wainwright & Co. | Matthew Caufield | → $12 | Reiterates | Buy → Buy | Get Alert |
11/01/2023 | Buy Now | — | William Blair | Tim Lugo | — | Initiates | → Outperform | Get Alert |
10/17/2023 | Buy Now | 492.59% | Brookline Capital | Kemp Dolliver | → $8 | Initiates | → Buy | Get Alert |
08/18/2023 | Buy Now | 788.89% | HC Wainwright & Co. | Matthew Caufield | → $12 | Reiterates | Buy → Buy | Get Alert |
08/11/2023 | Buy Now | 788.89% | HC Wainwright & Co. | Matthew Caufield | → $12 | Reiterates | Buy → Buy | Get Alert |
05/12/2023 | Buy Now | 788.89% | HC Wainwright & Co. | Matthew Caufield | → $12 | Reiterates | Buy → Buy | Get Alert |
04/19/2023 | Buy Now | 788.89% | HC Wainwright & Co. | Matthew Caufield | → $12 | Reiterates | → Buy | Get Alert |
04/03/2023 | Buy Now | 788.89% | HC Wainwright & Co. | Matthew Caufield | → $12 | Reiterates | → Buy | Get Alert |
10/05/2022 | Buy Now | 788.89% | HC Wainwright & Co. | Matthew Caufield | → $12 | Initiates | → Buy | Get Alert |
The latest price target for Eyenovia (NASDAQ:EYEN) was reported by HC Wainwright & Co. on July 24, 2024. The analyst firm set a price target for $12.00 expecting EYEN to rise to within 12 months (a possible 788.89% upside). 9 analyst firms have reported ratings in the last year.
The latest analyst rating for Eyenovia (NASDAQ:EYEN) was provided by HC Wainwright & Co., and Eyenovia reiterated their buy rating.
There is no last upgrade for Eyenovia
There is no last downgrade for Eyenovia.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Eyenovia, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Eyenovia was filed on July 24, 2024 so you should expect the next rating to be made available sometime around July 24, 2025.
While ratings are subjective and will change, the latest Eyenovia (EYEN) rating was a reiterated with a price target of $12.00 to $12.00. The current price Eyenovia (EYEN) is trading at is $1.35, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.